It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.

The FDA is weighing a ban on red dye No. 3, a synthetic dye used in some foods and drinks after concerns have been raised ...

The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...

A Boston-based company has passed an important hurdle in its effort to get FDA approval for its ovarian-cancer treatment.

( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

The U.S. government has updated its definition of the term “healthy,” overhauling national guidelines for the claim on food ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

Food safety advocates for years have pressured the Food and Drug Administration to ban red dye No. 3, used in bubble gum, ...